JP2008526249A - ｉｎｖｉｔｒｏ遺伝子タイピングのための方法および製品 - Google Patents

ｉｎｖｉｔｒｏ遺伝子タイピングのための方法および製品 Download PDF

Info

Publication number
JP2008526249A
JP2008526249A JP2007550872A JP2007550872A JP2008526249A JP 2008526249 A JP2008526249 A JP 2008526249A JP 2007550872 A JP2007550872 A JP 2007550872A JP 2007550872 A JP2007550872 A JP 2007550872A JP 2008526249 A JP2008526249 A JP 2008526249A
Authority
JP
Japan
Prior art keywords
seq
probe
genetic
genotype
probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526249A5 (enExample
Inventor
ラウレアーノ・シモン・ブエラ
アントニオ・マルティネス・マルティネス
ディエゴ・テヘドール・ヘルナンデス
エリサ・ヒメネス・ウリベ
モニカ・ロペス・マルティネス
マルタ・アルティエダ・オセナルデ
ロレナ・ヘルナンデス・ガルシア
Original Assignee
プロジェニカ・バイオファーマ・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200502423A external-priority patent/ES2326708B1/es
Application filed by プロジェニカ・バイオファーマ・エス・アー filed Critical プロジェニカ・バイオファーマ・エス・アー
Publication of JP2008526249A publication Critical patent/JP2008526249A/ja
Publication of JP2008526249A5 publication Critical patent/JP2008526249A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2007550872A 2005-01-13 2006-01-12 ｉｎｖｉｔｒｏ遺伝子タイピングのための方法および製品 Pending JP2008526249A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES200500089 2005-01-13
ES200502423A ES2326708B1 (es) 2005-10-05 2005-10-05 Metodos y productos para genotipado in vitro.
US75819206P 2006-01-12 2006-01-12
PCT/IB2006/000796 WO2006075254A2 (en) 2005-01-13 2006-01-12 Methods and products for in vitro genotyping

Publications (2)

Publication Number Publication Date
JP2008526249A true JP2008526249A (ja) 2008-07-24
JP2008526249A5 JP2008526249A5 (enExample) 2009-02-26

Family

ID=36677993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550872A Pending JP2008526249A (ja) 2005-01-13 2006-01-12 ｉｎｖｉｔｒｏ遺伝子タイピングのための方法および製品

Country Status (7)

Country Link
US (1) US7914990B2 (enExample)
EP (1) EP1836322B8 (enExample)
JP (1) JP2008526249A (enExample)
AU (1) AU2006205571B2 (enExample)
CA (1) CA2594730A1 (enExample)
MX (1) MX2007008506A (enExample)
WO (1) WO2006075254A2 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013507941A (ja) * 2009-10-21 2013-03-07 ゼネラル・エレクトリック・カンパニイ 生物学的試料中の複数の標的の検出
JP2015128399A (ja) * 2014-01-09 2015-07-16 東洋紡株式会社 Ｃｙｐ３ａ５の検出方法
JP2017061508A (ja) * 2011-11-25 2017-03-30 インデックス ファーマスーティカルズ アクチエボラグＩｎＤｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡＢ 結腸切除の予防のための方法
WO2019117192A1 (ja) * 2017-12-15 2019-06-20 東洋鋼鈑株式会社 一塩基多型検出用プローブの設計方法及びプローブセット
JP2020536500A (ja) * 2017-09-07 2020-12-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 溶質キャリアファミリー１４メンバー１（ｓｌｃ１４ａ１）の変異型及びその使用
WO2021162028A1 (ja) * 2020-02-14 2021-08-19 東レ株式会社 バイオチップの製造方法
JP2021535514A (ja) * 2018-08-30 2021-12-16 ライフ テクノロジーズ コーポレーション ジェノタイピングｐｃｒアッセイのための機械学習システム

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
JP5348840B2 (ja) 2003-02-20 2013-11-20 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 薬物を選択する方法
US8153363B2 (en) * 2005-01-13 2012-04-10 Progenika Biopharma S.A. Methods and products for in vitro genotyping
CA2911569C (en) 2005-11-29 2019-11-26 Children's Hospital Medical Center Optimization and individualization of medication selection and dosing
GB0613844D0 (en) * 2006-07-12 2006-08-23 Progenika Biopharma Sa Methods and products for in vitro genotyping
WO2008066164A1 (fr) * 2006-11-30 2008-06-05 Arkray, Inc. Ensemble d'amorces utilisé dans l'amplification du gène de l'obésité, réactif utilisé dans l'amplification du gène de l'obésité comprenant ledit ensemble d'amorce et son utilisation
WO2008066161A1 (en) * 2006-11-30 2008-06-05 Arkray, Inc. Primer set for amplification of nat2 gene, reagent for amplification of nat2 gene comprising the same, and use of the same
JPWO2008066163A1 (ja) * 2006-11-30 2010-03-11 アークレイ株式会社 Ｃｙｐ２ｃ９遺伝子増幅用プライマーセット、それを含むｃｙｐ２ｃ９遺伝子増幅用試薬およびその用途
ITMI20070504A1 (it) 2007-03-13 2008-09-14 Fond Irccs Ospedale Maggiore Metodo per la tipizzazione genomica di sistemi eritrocitari, sonde oligonucleotidiche e kit diagnostici relativi
JP4410269B2 (ja) * 2007-03-28 2010-02-03 株式会社東芝 Ｎ−アセチルトランスフェラーゼ２（ｎａｔ２）の遺伝子型を検出するための核酸プライマーセット、キット、及び該プライマーセットを用いた検出方法
US20100311052A1 (en) * 2007-06-29 2010-12-09 Biomonitor A/S Prognostic method for the determination of the suitability of biopharmaceutical treatment
WO2009048027A1 (ja) * 2007-10-09 2009-04-16 Arkray, Inc. 免疫関連遺伝子の多型の検出用プローブおよびその用途
CA2721651A1 (en) * 2008-04-18 2009-12-03 University Of Tennessee Research Foundation Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
WO2009130797A1 (ja) * 2008-04-22 2009-10-29 東洋鋼鈑株式会社 Abo式血液型を判定するためのプローブセット
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9580752B2 (en) * 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
US8835111B2 (en) 2009-03-12 2014-09-16 Brainco Biopharma S.L. Genotyping tool for improving the prognostic and clinical management of MS patients
WO2011027218A1 (en) * 2009-09-04 2011-03-10 Progenika Biopharma, S.A. High throughput detection of genomic copy number variations
US9558320B2 (en) * 2009-10-26 2017-01-31 Genomas, Inc. Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants
WO2011155531A1 (ja) * 2010-06-08 2011-12-15 独立行政法人国立がん研究センター 薬剤性肺障害の発症のリスク予測、該リスク予測のための遺伝子の検出方法及び検出用キット
ES2641600T3 (es) 2010-06-18 2017-11-10 Progenika Biopharma, S.A. Métodos de determinación de la presencia o la ausencia de segmentos genéticos
US8766034B2 (en) 2010-09-22 2014-07-01 Cedars-Sinai Medical Center TL1A model of inflammation fibrosis and autoimmunity
EP2471949B1 (en) * 2010-12-31 2013-12-25 Progenika Biopharma, S.A. Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W)
JP2012196209A (ja) * 2011-03-09 2012-10-18 Arkray Inc Ｃｙｐ３ａ遺伝子の多型検出用プローブ、多型検出方法、薬効評価方法及び多型検出用試薬キット
EP2535424B1 (en) * 2011-06-16 2015-08-05 Gendiag.exe, S.L. SNPs associated with thromboemoblic disease
US10557170B2 (en) 2011-06-16 2020-02-11 Gendiag.Exe, S.L. Thromboembolic disease markers
EP2721171A1 (en) * 2011-06-17 2014-04-23 Progenika Biopharma, S.A. Discrimination of blood type variants
AR088867A1 (es) * 2011-11-15 2014-07-16 Acgt Intellectual Ltd Metodo y aparato para detectar variacion(es) del acido nucleico
ES2759782T3 (es) * 2012-01-18 2020-05-12 Shanghai Blood Centre Procedimiento de detección por PCR múltiplex para tipos sanguíneos humanos poco comunes y kit
JP6028300B2 (ja) * 2012-08-31 2016-11-16 東洋鋼鈑株式会社 Ａｂｏ式血液型を判定するためのプライマーセット及びプローブ
US20140274763A1 (en) * 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to pain treatments
EP3639841B1 (en) 2013-03-27 2023-09-06 Cedars-Sinai Medical Center Treating fibrosis by inhibiting tl1a
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
JP7082945B2 (ja) 2016-03-17 2022-06-09 シーダーズ―シナイ メディカル センター Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法
US11699069B2 (en) * 2017-07-13 2023-07-11 Helix, Inc. Predictive assignments that relate to genetic information and leverage machine learning models
EP3697933A4 (en) 2017-10-20 2021-12-08 The Governors of the University of Alberta SINGLE NUCLEOTIDE POLYMORPHISMS AND FEEDING EFFICIENCY IN Cattle
CN112442532B (zh) * 2020-08-27 2023-09-26 深圳市卫生健康发展研究中心 同时检测20种葡萄糖-6-磷酸脱氢酶缺乏症的引物组及试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165839A2 (en) * 1999-03-26 2002-01-02 Whitehead Institute For Biomedical Research Universal arrays
WO2001029268A2 (en) 1999-10-18 2001-04-26 Curagen Corporation Method for identifying interacting gene products
EP1287162A2 (en) * 1999-10-21 2003-03-05 Case Western Reserve University Gene expression profiling of inflammatory bowel disease
CA2490766A1 (en) * 2002-06-28 2004-01-08 Applera Corporation A system and method for snp genotype clustering

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013507941A (ja) * 2009-10-21 2013-03-07 ゼネラル・エレクトリック・カンパニイ 生物学的試料中の複数の標的の検出
JP2017061508A (ja) * 2011-11-25 2017-03-30 インデックス ファーマスーティカルズ アクチエボラグＩｎＤｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡＢ 結腸切除の予防のための方法
US9795627B2 (en) 2011-11-25 2017-10-24 Index Pharmaceuticals Ab Method for prevention of colectomy
JP2015128399A (ja) * 2014-01-09 2015-07-16 東洋紡株式会社 Ｃｙｐ３ａ５の検出方法
JP2020536500A (ja) * 2017-09-07 2020-12-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 溶質キャリアファミリー１４メンバー１（ｓｌｃ１４ａ１）の変異型及びその使用
WO2019117192A1 (ja) * 2017-12-15 2019-06-20 東洋鋼鈑株式会社 一塩基多型検出用プローブの設計方法及びプローブセット
JP2021535514A (ja) * 2018-08-30 2021-12-16 ライフ テクノロジーズ コーポレーション ジェノタイピングｐｃｒアッセイのための機械学習システム
JP7308261B2 (ja) 2018-08-30 2023-07-13 ライフ テクノロジーズ コーポレーション ジェノタイピングｐｃｒアッセイのための機械学習システム
WO2021162028A1 (ja) * 2020-02-14 2021-08-19 東レ株式会社 バイオチップの製造方法
JPWO2021162028A1 (enExample) * 2020-02-14 2021-08-19
JP7706698B2 (ja) 2020-02-14 2025-07-14 東レ株式会社 バイオチップの製造方法

Also Published As

Publication number Publication date
US7914990B2 (en) 2011-03-29
WO2006075254A3 (en) 2007-03-22
MX2007008506A (es) 2010-05-17
CA2594730A1 (en) 2006-07-20
EP1836322B8 (en) 2017-01-11
AU2006205571A1 (en) 2006-07-20
EP1836322A2 (en) 2007-09-26
US20080070253A1 (en) 2008-03-20
EP1836322B1 (en) 2016-09-07
WO2006075254A2 (en) 2006-07-20
AU2006205571B2 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
US7914990B2 (en) Methods and products for in vitro genotyping
US8153363B2 (en) Methods and products for in vitro genotyping
Li et al. A novel SNPs detection method based on gold magnetic nanoparticles array and single base extension
JP5881420B2 (ja) 自閉症関連遺伝子マーカー
EP2847593A1 (en) Methods for predicting and detecting cancer risk
CA2409774A1 (en) Methods for genetic analysis of dna to detect sequence variances
EP2061910B1 (en) Prognostic method
US7732138B2 (en) Rapid genotyping analysis and the device thereof
JP2009516516A (ja) ヌクレオチド配列を同定するための方法及びプローブ
US20160060696A1 (en) Method for the identification by molecular techniques of genetic variants that encode no d antigen (d-) and altered c antigen (c+w)
JP4283578B2 (ja) 不一致増幅物質を含むプローブ核酸を用いる標的配列の検出方法、プローブ核酸および標的配列検出用アッセイキット
ES2361800B1 (es) Metodos y productos para genotipado in vitro de variaciones genicas humanas asociadas a antigenos eritrocitarios humanos.
KR101167942B1 (ko) Ａｌｇ12 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 자폐 스펙트럼 장애 분석방법
ES2326708B1 (es) Metodos y productos para genotipado in vitro.
Oitmaa et al. Molecular diagnosis of Down syndrome using quantitative APEX‐2 microarrays
JP2009125018A (ja) ハプロタイプの検出法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110920

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120417